Overcoming the Resistance Hurdle: PK-PD Target Attainment Analyses of Rezafungin (CD101) for Candida Albicans and Candida Glabrata

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.02614-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Susceptibility Testing of Candida Albicans and Candida Glabrata to Glycyrrhiza Glabra L.

Industrial Crops and Products
AgronomyCrop Science
2017English

Transcriptional Analyses of Antifungal Drug Resistance in Candida Albicans

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Simple Two-Medium System for Isolation and Identification of Candida Albicans and Candida Glabrata Suitable for Use With Gynecological Species.

Japanese Journal of Medical Mycology
1988English

Genetic Drivers of Multidrug Resistance in Candida Glabrata

Frontiers in Microbiology
Microbiology
2016English

Candida Albicans

Current Biology
GeneticsMolecular BiologyBiochemistryBiological SciencesNeuroscienceAgricultural
2012English

Comparison of Pathogenesis and Host Immune Responses to Candida Glabrata and Candida Albicans in Systemically Infected Immunocompetent Mice

Infection and Immunity
ParasitologyInfectious DiseasesImmunologyMicrobiology
2001English

Evolution of Drug Resistance in Candida Albicans

Annual Review of Microbiology
Microbiology
2002English

Multi-Species Biofilm of Candida Albicans and Non-Candida Albicans Candida Species on Acrylic Substrate

Journal of Applied Oral Science
MedicineDentistry
2012English

Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy